In 2010 Htwe et al. showed a significant (p = 0.001) stronger expression of Gal-3 in the advancing follicular cells at the periphery of thyroid cancer lesions, which was more pronounced in PTC than follicular carcinoma of the thyroid [33]. This evidence concerns the gene LGALS3 and thyroid cancer.